Bosutinib high density lipoprotein nanoformulation has potent tumour radiosensitisation effects

Disruption of the cell cycle is among the most effective approach to increase tumour cells’ radio-sensitivity. However, the presence of dose-limiting side effects hampers the clinical use of tyrosine kinase inhibitors targeting the cell cycle. Towards addressing this challenge, we identified a bosut...

Descripción completa

Detalles Bibliográficos
Autores principales: Dehghankelishadi, Pouya, Badiee, Parisa, Maritz, Michelle F., Dmochowska, Nicole, Thierry, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028769/
https://www.ncbi.nlm.nih.gov/pubmed/36945003
http://dx.doi.org/10.1186/s12951-023-01848-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028769/
https://www.ncbi.nlm.nih.gov/pubmed/36945003
http://dx.doi.org/10.1186/s12951-023-01848-9

Ejemplares similares